-
1
-
-
80051580618
-
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths
-
Siegel R, Ward E, Brawley O, Jemal A, (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 212-236
-
-
Siegel, R.1
Ward, E.2
Brawley, O.3
Jemal, A.4
-
2
-
-
0037050352
-
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
-
Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, et al. (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98.
-
(2002)
N Engl J Med
, vol.346
, pp. 92-98
-
-
Schiller, J.H.1
Harrington, D.2
Belani, C.P.3
Langer, C.4
Sandler, A.5
-
3
-
-
49049089802
-
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
-
Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, et al. (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26: 3543-3551.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3543-3551
-
-
Scagliotti, G.V.1
Parikh, P.2
von Pawel, J.3
Biesma, B.4
Vansteenkiste, J.5
-
4
-
-
0042413836
-
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group
-
Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, et al. (2003) Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 21: 3016-3024.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3016-3024
-
-
Fossella, F.1
Pereira, J.R.2
von Pawel, J.3
Pluzanska, A.4
Gorbounova, V.5
-
5
-
-
80052505923
-
Evaluation of current practice: management of chemotherapy-related toxicities
-
Lheureux S, Clarisse B, Launay-Vacher V, Gunzer K, Delcambre-Lair C, et al. (2011) Evaluation of current practice: management of chemotherapy-related toxicities. Anticancer Drugs 22: 919-925.
-
(2011)
Anticancer Drugs
, vol.22
, pp. 919-925
-
-
Lheureux, S.1
Clarisse, B.2
Launay-Vacher, V.3
Gunzer, K.4
Delcambre-Lair, C.5
-
6
-
-
53749097825
-
Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials
-
NSCLC Meta-Analyses Collaborative Group
-
NSCLC Meta-Analyses Collaborative Group (2008) Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 26: 4617-4625.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4617-4625
-
-
-
7
-
-
0029963622
-
Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer
-
Nebert DW, McKinnon RA, Puga A, (1996) Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 15: 273-280.
-
(1996)
DNA Cell Biol
, vol.15
, pp. 273-280
-
-
Nebert, D.W.1
McKinnon, R.A.2
Puga, A.3
-
8
-
-
79551543927
-
UV-induced photolesions elicit ATR-kinase-dependent signaling in non-cycling cells through nucleotide excision repair-dependent and -independent pathways
-
Vrouwe MG, Pines A, Overmeer RM, Hanada K, Mullenders LH, (2011) UV-induced photolesions elicit ATR-kinase-dependent signaling in non-cycling cells through nucleotide excision repair-dependent and-independent pathways. J Cell Sci 124: 435-446.
-
(2011)
J Cell Sci
, vol.124
, pp. 435-446
-
-
Vrouwe, M.G.1
Pines, A.2
Overmeer, R.M.3
Hanada, K.4
Mullenders, L.H.5
-
9
-
-
33745951429
-
Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer
-
Bernig T, Chanock SJ, (2006) Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev Mol Diagn 6: 319-331.
-
(2006)
Expert Rev Mol Diagn
, vol.6
, pp. 319-331
-
-
Bernig, T.1
Chanock, S.J.2
-
10
-
-
34249812370
-
Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer
-
Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, et al. (2007) Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res 13: 2876-2881.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2876-2881
-
-
Giachino, D.F.1
Ghio, P.2
Regazzoni, S.3
Mandrile, G.4
Novello, S.5
-
11
-
-
66649120041
-
Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population
-
Wu W, Zhang W, Qiao R, Chen D, Wang H, et al. (2009) Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population. Clin Cancer Res 15: 3889-3895.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3889-3895
-
-
Wu, W.1
Zhang, W.2
Qiao, R.3
Chen, D.4
Wang, H.5
-
12
-
-
77649238161
-
Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients
-
Chen S, Huo X, Lin Y, Ban H, Lin Y, et al. (2010) Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients. Int J Hyg Environ Health 213: 140-145.
-
(2010)
Int J Hyg Environ Health
, vol.213
, pp. 140-145
-
-
Chen, S.1
Huo, X.2
Lin, Y.3
Ban, H.4
Lin, Y.5
-
14
-
-
0345256652
-
Cisplatin: mode of cytotoxic action and molecular basis of resistance
-
Siddik ZH, (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279.
-
(2003)
Oncogene
, vol.22
, pp. 7265-7279
-
-
Siddik, Z.H.1
-
15
-
-
0034688940
-
DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy
-
van de Vaart PJ, Belderbos J, de Jong D, Sneeuw KC, Majoor D, et al. (2000) DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy. Int J Cancer 89: 160-166.
-
(2000)
Int J Cancer
, vol.89
, pp. 160-166
-
-
van de Vaart, P.J.1
Belderbos, J.2
de Jong, D.3
Sneeuw, K.C.4
Majoor, D.5
-
16
-
-
0036270993
-
DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis
-
Bernstein C, Bernstein H, Payne CM, Garewal H, (2002) DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 511: 145-178.
-
(2002)
Mutat Res
, vol.511
, pp. 145-178
-
-
Bernstein, C.1
Bernstein, H.2
Payne, C.M.3
Garewal, H.4
-
17
-
-
4344567395
-
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy
-
Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, et al. (2004) XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 22: 2594-2601.
-
(2004)
J Clin Oncol
, vol.22
, pp. 2594-2601
-
-
Gurubhagavatula, S.1
Liu, G.2
Park, S.3
Zhou, W.4
Su, L.5
-
18
-
-
20044368468
-
Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients
-
Suk R, Gurubhagavatula S, Park S, Zhou W, Su L, et al. (2005) Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Clin Cancer Res 11: 1534-1538.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 1534-1538
-
-
Suk, R.1
Gurubhagavatula, S.2
Park, S.3
Zhou, W.4
Su, L.5
-
19
-
-
33646241783
-
Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer
-
Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, et al. (2006) Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 12: 2101-2108.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 2101-2108
-
-
Moreno, V.1
Gemignani, F.2
Landi, S.3
Gioia-Patricola, L.4
Chabrier, A.5
-
20
-
-
33644870366
-
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
-
Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, et al. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27: 560-567.
-
(2006)
Carcinogenesis
, vol.27
, pp. 560-567
-
-
Zienolddiny, S.1
Campa, D.2
Lind, H.3
Ryberg, D.4
Skaug, V.5
-
21
-
-
38149140159
-
A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer
-
Lin Z, Zhang X, Tuo J, Guo Y, Green B, et al. (2008) A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer. Hum Mutat 29: 113-122.
-
(2008)
Hum Mutat
, vol.29
, pp. 113-122
-
-
Lin, Z.1
Zhang, X.2
Tuo, J.3
Guo, Y.4
Green, B.5
-
22
-
-
33746360586
-
Identification of MMS19 domains with distinct functions in NER and transcription
-
Hatfield MD, Reis AM, Obeso D, Cook JR, Thompson DM, et al. (2006) Identification of MMS19 domains with distinct functions in NER and transcription. DNA Repair (Amst) 5: 914-924.
-
(2006)
DNA Repair (Amst)
, vol.5
, pp. 914-924
-
-
Hatfield, M.D.1
Reis, A.M.2
Obeso, D.3
Cook, J.R.4
Thompson, D.M.5
-
23
-
-
0027994603
-
A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase
-
Fisher RP, Morgan DO, (1994) A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78: 713-724.
-
(1994)
Cell
, vol.78
, pp. 713-724
-
-
Fisher, R.P.1
Morgan, D.O.2
-
24
-
-
80053617155
-
The role of XPC: implications in cancer and oxidative DNA damage
-
Melis JP, Luijten M, Mullenders LH, van Steeg H, (2011) The role of XPC: implications in cancer and oxidative DNA damage. Mutat Res 728: 107-117.
-
(2011)
Mutat Res
, vol.728
, pp. 107-117
-
-
Melis, J.P.1
Luijten, M.2
Mullenders, L.H.3
van Steeg, H.4
-
25
-
-
33750579074
-
RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer
-
Bepler G, Kusmartseva I, Sharma S, Gautam A, Cantor A, et al. (2006) RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer. J Clin Oncol 24: 4731-4737.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4731-4737
-
-
Bepler, G.1
Kusmartseva, I.2
Sharma, S.3
Gautam, A.4
Cantor, A.5
-
26
-
-
78149286935
-
Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer
-
Sakano S, Hinoda Y, Sasaki M, Wada T, Matsumoto H, et al. (2010) Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer. Pharmacogenomics 11: 1377-1387.
-
(2010)
Pharmacogenomics
, vol.11
, pp. 1377-1387
-
-
Sakano, S.1
Hinoda, Y.2
Sasaki, M.3
Wada, T.4
Matsumoto, H.5
-
27
-
-
67650627436
-
Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array
-
Kweekel DM, Antonini NF, Nortier JW, Punt CJ, Gelderblom H, et al. (2009) Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array. Br J Cancer 101: 357-362.
-
(2009)
Br J Cancer
, vol.101
, pp. 357-362
-
-
Kweekel, D.M.1
Antonini, N.F.2
Nortier, J.W.3
Punt, C.J.4
Gelderblom, H.5
-
28
-
-
52149093686
-
XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population
-
Wang Z, Xu B, Lin D, Tan W, Leaw S, et al. (2008) XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population. Lung Cancer 62: 99-104.
-
(2008)
Lung Cancer
, vol.62
, pp. 99-104
-
-
Wang, Z.1
Xu, B.2
Lin, D.3
Tan, W.4
Leaw, S.5
|